Kloramfenikol Minims Bausch + Lomb Ireland Limited (Chloramphenicol)

Chloramphenicol interferes with bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation. This bacteriostatic action stops bacterial growth on the ocular surface, allowing the body's immune defenses to clear the infection.

The dosing regimen for Kloramfenikol Minims is determined by the prescribing eye‑care professional. Typical regimens involve one to two drops per affected eye, administered several times daily for a limited period, but the exact schedule should follow the prescriber’s instructions.

Safety data for chloramphenicol ophthalmic use in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with fluoroquinolone eye drops, chloramphenicol offers a broad spectrum against Gram‑positive and some Gram‑negative organisms but has a lower risk of developing resistance. However, fluoroquinolones may be preferred for resistant strains, while chloramphenicol remains a cost‑effective option for many routine infections.

Store the ophthalmic solution at room temperature, below 25 °C, in its original container. Protect it from direct sunlight, moisture and extreme temperatures. Keep the bottle tightly closed when not in use to maintain sterility.

The solution is applied topically as eye drops. The patient should wash hands, tilt the head back, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. Avoid touching the dropper tip to any surface.

Serious risks include corneal ulceration, severe allergic reactions such as anaphylaxis, and rare systemic effects like bone‑marrow suppression if absorbed in significant amounts. Immediate medical attention is required if vision changes, severe pain or systemic symptoms occur.

Patients with a known hypersensitivity to chloramphenicol or other amphenicols should avoid this product. It is also contraindicated in eyes with severe epithelial damage unless directed by a specialist, and it should not be used for prolonged periods without medical supervision.